Lack of interaction between a polymorphism in the dopamine D2 receptor gene and the clinical features of migraine

Cephalalgia

Volumn 24, Issue 6, 2004, Pages 503-507

  Rebaudengo, N ^a   Rainero, I ^b   Parziale, A ^a   Rosina, F ^a   Pavanelli, E ^a   Rubino, E ^b   Mazza, C ^b   Ostacoli, L ^b   Furlan, P M ^b  

^a Gradenigo Hospital   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Aura; Dopamine D2 receptor gene; Genetic; Migraine; Polymorphism

Indexed keywords

DOPAMINE 2 RECEPTOR;

ADULT; ARTICLE; CLINICAL FEATURE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; ONSET AGE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE;

ADULT; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2;

EID: 2942612194     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2004.00689.x     Document Type: Article

References (23)

1. Gardner K. The genetic basis of migraine: how much do we know? Can J Neurol Sci 1999; 26 (Suppl. 3):S37-43.
2. Montagna P. Molecular genetics of migraine headaches: a review. Cephalalgia 2000; 20:3-14.
3. Silberstein SD, Young WB, Mendizabal JE, Rothrock JF, Alam AS. Acute migraine treatment with droperidol: a randomized, double-blind, placebo-controlled trial. Neurology 2003; 60:315-21.
4. Bigal ME, Bordini CA, Speciali JG. Intravenous chlorpromazine in the emergency department treatment of migraines: a randomized controlled trial. J Emerg Med 2002; 23:141-8.
5. Somerville BW, Herrmann WM. Migraine prophylaxis with Lisuride hydrogen maleate - a double blind study of Lisuride versus placebo. Headache 1978; 18:75-9.
6. Blin O, Azulay JP, Masson G, Aubrespy G, Serratrice G. Apomorphine-induced yawning in migraine patients: enhanced responsiveness. Clin Neuropharmacol 1991; 14:91-5.
7. Cerbo R, Barbanti P, Buzzi MG, Fabbrini G, Brusa L, Roberti C et al. Dopamine hypersensitivity in migraine: role of the apomorphine test. Clin Neuropharmacol 1997; 20:36-41.
8. Barbanti P, Fabbrini G, Ricci A, Pascali MP, Bronzetti E, Amenta F et al. Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes. Cephalalgia 2000; 20:15-9.
9. Peroutka SJ, Wilhoit T, Jones K. Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles. Neurology 1997; 49:201-6.
10. Peroutka SJ, Price SC, Wilhoit TL, Jones KW. Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles. Mol Med 1998; 4:14-21.
11. Dichgans M, Forderreuther S, Deiterich M, Pfaffenrath V, Gasser T. The D2 receptor NcoI allele: absence of allelic association with migraine with aura. Neurology 1998; 51:928.
12. Lea RA, Dohy A, Jordan K, Quinlan S, Brimage PJ, Griffiths LR. Evidence for allelic association of the dopamine β-hydroxylase gene (DBH) with susceptibility to typical migraine. Neurogenetics 2000; 3:35-40.
13. Del Zompo M, Cherchi A, Palmas MA, Ponti M, Bocchetta A, Gessa GL, Piccardi MP. Association between dopamine receptor genes and migraine without aura in a Sardinian sample. Neurology 1998; 51:781-6.
14. Russell G, Shaw D, Clair DS. The -141C Ins/Del polymorphism of the dopamine D2 receptor gene is not associated with either migraine or Parkinson's disease. Psychiatr Genet 2001; 11:49-52.
15. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgia and facial pain. Cephalalgia 1988; 8 (Suppl. 7):1-96.
16. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67:361-70.
17. Snaith RP, Zigmond AS. The hospital anxiety and depression scale. Manual. London: NFER-Nelson, 1994.
18. Hartmaier SL, Santanello NC, Epstein RS, Silberstein SD. Development of a brief 24-hour migraine-specific quality of life questionnaire. Headache 1995; 35:320-9.
19. Santanello NC, Hartmaier SL, Epstein RS, Silberstein SD. Validation of a new quality of life questionnaire for acute migraine headache. Headache 1995; 35:330-7.
20. Grandy DK, Marchionni MA, Makam H, Stofko RE, Alfano M, Frothingham L et al. Cloning of the cDNA and gene for a human D2 dopamine receptor. Proc Natl Acad Sci USA 1989; 86:9762-6.
21. Monsma FJ Jr, McVittie LD, Gerfen CR, Mahan LC, Sibley DR. Multiple D2 dopamine receptors produced by alternative RNA splicing. Nature 1989; 342:926-9.
22. Noble EP. D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet 2003; 116 (Suppl. 1):103-25.
23. Wong AH, Buckle CE, Van Tol HH. Polymorphisms in dopamine receptors: what do they tell us? Eur J Pharmacol 2000; 410:183-203.